Erratum: CD95L cell surface cleavage triggers a prometastatic signaling pathway in triple-negative breast cancer (Cancer Research (2013) 73 (6711–6721) DOI: 10.1158/0008-5472.CAN-13-1794)

1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

In the original version of this article (1), the Western blot image used in Fig. 5D to represent CD95 lysate was inadvertently duplicated from the image of c-yes lysate. The image has been replaced with the intended image for CD95 lysate. In addition, in Supplementary Fig. S5H MDA-MB-468 cells, the cell migration images for control and cl-CD95L in the untreated group were inadvertently duplicated from the control group of Supplementary Fig. S5C MDA-MB-231 cells. The images have been replaced with the intended images for MDA-MB-468 cells. These corrections are reflected in the latest online HTML and PDF versions of the article. The authors regret these errors.

Cite

CITATION STYLE

APA

Malleter, M., Tauzin, S., Bessede, A., Castellano, R., Goubard, A., Godey, F., … Legembre, P. (2020, February 1). Erratum: CD95L cell surface cleavage triggers a prometastatic signaling pathway in triple-negative breast cancer (Cancer Research (2013) 73 (6711–6721) DOI: 10.1158/0008-5472.CAN-13-1794). Cancer Research. American Association for Cancer Research Inc. https://doi.org/10.1158/0008-5472.CAN-19-3636

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free